Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir ointment for anal fissure in adults without herpes simplex virus infection
IRCT20200906048636N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of aciclovir and diltiazem in anal fissure (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Alterations in the severity of pain. Started Dec 2021; status: completed.
02
Drugs
aciclovirdiltiazem
03
Conditions
anal fissure
Beyond the preview
Go deeper on IRCT20200906048636N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200906048636N1.